Mechanism of Action of Nitrous Oxide

Introduction

Nitrous oxide is an inhalational anesthetic gas with analgesic and sedative properties. It is widely used in anesthesia practice and procedural sedation, especially for short procedures. It has a rapid onset and recovery due to low blood solubility. Nitrous oxide provides good analgesia but relatively weak anesthetic potency, so it is often used in combination with other anesthetic agents.


Mechanism of Action (Step-wise)

  1. Nitrous oxide acts as an antagonist at N-methyl-D-aspartate (NMDA) receptors.
  2. NMDA receptors are involved in excitatory glutamatergic neurotransmission.
  3. Blocking NMDA receptors reduces excitatory neuronal activity.
  4. This contributes to analgesia and sedation.
  5. Nitrous oxide also stimulates release of endogenous opioid peptides.
  6. These opioids activate μ-opioid receptors in the central nervous system.
  7. Activation of opioid receptors enhances analgesic effects.
  8. It increases activity of descending inhibitory pain pathways from the brainstem.
  9. Nitrous oxide may also modulate GABAergic neurotransmission indirectly.
  10. The combined effects produce analgesia, mild anesthesia, and sedation.

A key exam point is that nitrous oxide produces analgesia primarily through NMDA receptor antagonism and endogenous opioid release.

Mechanism of action of Nitrous Oxide
MOA of Nitrous Oxide
Mechanism of Action of Nitrous Oxide Flowchart
Flowchart of mechanism of action of Nitrous Oxide

Pharmacokinetics

Nitrous oxide is administered via inhalation. It has very low blood-gas partition coefficient, leading to rapid onset and recovery. It is not significantly metabolized and is excreted unchanged via the lungs. Because of its rapid elimination, its effects wear off quickly after discontinuation. It can diffuse into air-filled spaces, which is clinically important.


Clinical Uses

Nitrous oxide is used for procedural sedation, dental procedures, and as an adjunct to general anesthesia. It provides analgesia in labor and minor surgical procedures. It is often combined with other anesthetic agents to reduce the required dose of more potent drugs.


Adverse Effects

Common adverse effects include nausea, vomiting, dizziness, and euphoria. Prolonged exposure can inactivate vitamin B12, leading to megaloblastic anemia and neurological effects. It can expand air-filled spaces, making it contraindicated in conditions such as pneumothorax or bowel obstruction. Diffusion hypoxia may occur after discontinuation.


Comparative Analysis

FeatureNitrous OxideHalothanePropofol
TypeInhalational anestheticInhalational anestheticIntravenous anesthetic
AnalgesiaStrongWeakMinimal
OnsetVery rapidModerateRapid
RecoveryRapidModerateRapid
PotencyLowHighHigh
Special effectNMDA blockadeCardiac depressionCNS depression

Nitrous oxide differs from halothane by having strong analgesic effects but lower anesthetic potency. Compared to propofol, it is inhalational and provides better analgesia.


MCQs

  1. Nitrous oxide primarily blocks which receptor?
    a) GABA receptor
    b) NMDA receptor
    c) Dopamine receptor
    d) Histamine receptor

Answer: b) NMDA receptor

  1. NMDA receptor blockade leads to:
    a) Increased excitation
    b) Reduced excitation
    c) Increased calcium
    d) Increased sodium

Answer: b) Reduced excitation

  1. Nitrous oxide increases release of:
    a) Insulin
    b) Endogenous opioids
    c) Calcium
    d) Sodium

Answer: b) Endogenous opioids

  1. Nitrous oxide is administered via:
    a) Oral route
    b) Intravenous route
    c) Inhalation
    d) Intramuscular route

Answer: c) Inhalation

  1. Nitrous oxide has:
    a) High blood solubility
    b) Low blood solubility
    c) No solubility
    d) Variable solubility

Answer: b) Low blood solubility

  1. Nitrous oxide is used in:
    a) Hypertension
    b) Anesthesia
    c) Diabetes
    d) Asthma

Answer: b) Anesthesia

  1. A common adverse effect is:
    a) Hypoglycemia
    b) Nausea
    c) Hypercalcemia
    d) Bradycardia

Answer: b) Nausea

  1. Nitrous oxide can cause deficiency of:
    a) Vitamin A
    b) Vitamin B12
    c) Vitamin C
    d) Vitamin D

Answer: b) Vitamin B12

  1. Nitrous oxide is contraindicated in:
    a) Hypertension
    b) Pneumothorax
    c) Diabetes
    d) Asthma

Answer: b) Pneumothorax

  1. Nitrous oxide is excreted via:
    a) Kidney
    b) Liver
    c) Lungs
    d) Skin

Answer: c) Lungs

  1. Nitrous oxide has which onset?
    a) Slow
    b) Moderate
    c) Rapid
    d) Delayed

Answer: c) Rapid

  1. Nitrous oxide produces analgesia mainly by:
    a) COX inhibition
    b) NMDA blockade
    c) Beta blockade
    d) ACE inhibition

Answer: b) NMDA blockade


FAQs

What is the mechanism of action of nitrous oxide?
It blocks NMDA receptors and enhances endogenous opioid activity to produce analgesia and sedation.

Why does nitrous oxide act rapidly?
Due to its low blood solubility.

What is diffusion hypoxia?
A decrease in oxygen levels after discontinuation due to rapid elimination of nitrous oxide.

Why does nitrous oxide affect vitamin B12?
It inactivates vitamin B12, affecting DNA synthesis.

Where is nitrous oxide excreted?
Via the lungs.

Why is nitrous oxide contraindicated in pneumothorax?
It expands air-filled spaces.


References

Goodman & Gilman’s The Pharmacological Basis of Therapeutics – General Anesthetics
https://accessmedicine.mhmedical.com/book.aspx?bookid=3191

Katzung: Basic and Clinical Pharmacology – Anesthetic Agents
https://accessmedicine.mhmedical.com/content.aspx?bookid=3382

Tripathi: Essentials of Medical Pharmacology – General Anesthetics
https://www.jaypeedigital.com

Harrison’s Principles of Internal Medicine – Anesthesia and Sedation
https://accessmedicine.mhmedical.com

Author

  • Harsh Singh Author Pharmacy Freak

    Harsh Singh Rajput is a pharmacist currently working at ESIC and holds an MBA in Pharmaceutical Management from NIPER Hyderabad. He has a strong academic record with top ranks in national-level pharmacy exams, including AIR 61 in NIPER 2024 (MS/M.Pharm), AIR 27 in NIPER MBA, AIR 147 in GPAT 2024, AIR 907 in GPAT 2023, and AIR 6 in AIIMS CRE-2025 for Drug Store Keeper. At PharmacyFreak.com, he contributes expert content, exam strategies, and practical guidance for future pharmacists.
    Mail- harsh@pharmacyfreak.com

Leave a Comment

PRO
Ad-Free Access
$3.99 / month
  • No Interruptions
  • Faster Page Loads
  • Support Content Creators